Our direct research into the causes, treatment, and prevention of cancer, AIDS,
and related diseases. From basic research into the molecular mechanisms of carcinogenesis
to pre-clinical investigation of potential new treatments, scientists at NCI-Frederick
are studying the origins of cancer—the genes, proteins, and signals involved in
initiation—and identifying possible targets to treat or prevent the disease.
Programs encompass investigators, organized within a specific field of research,
who are working together to solve a complex scientific problem.
AIDS and Cancer Virus Program - Jeffrey D. Lifson, M.D.
Advanced Technology Program (ATP) - Atsuo
Biopharmaceutical Development Program - George
Cancer and Inflammation Program
- Giorgio Trinchieri, M.D.
CCR Nanobiology Program
- Robert Blumenthal, Ph.D.
Clinical Monitoring Research Program (CMRP)
- Beth Baseler, M.S.
Clinical Services Program - Michael W. Baseler, Ph.D.
Developmental Therapeutics Program - Jerry
M. Collins, Ph.D., Associate Director
HIV Drug Resistance Program
- Stephen H. Hughes, Ph.D.
Laboratory Animal Sciences Program - Lionel Feigenbaum,
Mouse Cancer Genetics Program
- Lino Tessarollo, Ph.D. (Acting Program Director)